Dr. David E. Einspahr
Claim this profileCotton O'Neil Cancer Center / Stormont Vail Health
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
9 reported clinical trials
31 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage II
Stage I
Stage III
2Lung Cancer
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials David E. Einspahr is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about David E. Einspahr
Clinical Trial Related5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments David E. Einspahr has experience with
- Pembrolizumab
- Pemetrexed Disodium
- Carboplatin
- Gemcitabine Hydrochloride
- Paclitaxel
- Gemcitabine
Breakdown of trials David E. Einspahr has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
B Cell Malignancies
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David E. Einspahr specialize in?
David E. Einspahr focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is David E. Einspahr currently recruiting for clinical trials?
Yes, David E. Einspahr is currently recruiting for 5 clinical trials in Topeka Kansas. If you're interested in participating, you should apply.
Are there any treatments that David E. Einspahr has studied deeply?
Yes, David E. Einspahr has studied treatments such as Pembrolizumab, Pemetrexed Disodium, Carboplatin.
What is the best way to schedule an appointment with David E. Einspahr?
Apply for one of the trials that David E. Einspahr is conducting.
What is the office address of David E. Einspahr?
The office of David E. Einspahr is located at: Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka, Kansas 66606 United States. This is the address for their practice at the Cotton O'Neil Cancer Center / Stormont Vail Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.